INS and type 2 diabetes mellitus: After adjustment for fibrinogen (F = 18.1, df = 1, P < 0.0001), HbA1c (F = 9.5, df = 1, P = 0.003), T2DM duration (F = 10.5, df = 1, P = 0.001) and insulin therapy (F = 1.6, df = 1, P = 0.21), glucose concentration significantly influenced clot lysis time (F = 8.0, df = 2, P = 0.0005).